Disparities in antiretroviral prescribing for blacks and whites in the United States

Journal of the National Medical Association

Volumn 101, Issue 11, 2009, Pages 1140-1148

  Oramasionwu, Christine U ^a,b   Skinner, Jeff ^c   Ryan, Laurajo ^a,b   Frei, Christopher R ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Health disparities; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; HEALTH DISPARITY; HEALTH SERVICE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

EID: 69949157882     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0027-9684(15)31110-x     Document Type: Article

References (20)

1. Patella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-860.
2. Patella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34.
3. Cocohoba J, Wang QJ, Cox C, et al. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. J Acquir Immune Defic Syndr. 2008;47:377-383.
4. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38:96-103.
5. McNaghten AD, Hanson DL, Dworkin MS, et al. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2003;32:499-505.
6. Reif S, Whetten K, Thielman N. Association of race and gender with use of antiretroviral therapy among HIV-infected individuals in the southeastern United States. South Med J. 2007;100:775-781.
7. Cherry DK, Woodwell DA, Rechtsteiner EA. National Ambulatory Medical Care Survey: 2005 summary. Adv Data. 2007:1-39.
8. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents; January 28, 2000.
9. Force Public Health Service Task. Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States; July 8, 2008.
10. Holodniy M, Hornberger J, Rapoport D, et al. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004). J Acquir Immune Defic Syndr. 2007;44:20-29.
11. McGinnis KA, Fine MJ, Sharma RK, et al. Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health. 2003;93:1728-1733.
12. Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease pro-gression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS. 2001;15:1115-1123.
13. US Department of Health and Human Services, CDC. HIV/AIDS Surveillance Report: Cases of HIV infection and AIDS in the United States and dependent areas, 2005.
14. Monga HK, Rodriguez-Barradas MC, Breaux K, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;33:240-247.
15. Estrada AL. Health disparities among African-American and Hispanic drug injectors - HIV, AIDS, hepatitis B virus and hepatitis C virus: a review. AIDS. 2005;19(3)(suppl):S47-S52.
16. Cooper H, Friedman SR, Tempalski B, et al. Racial/ethnic disparities in injection drug use in large US metropolitan areas. Ann Epidemiol. 2005;15:326-334.
17. Schwarcz S, Hsu L, Dilley JW, et al. Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. J Acquir Immune Defic Syndr. 2006;43:491-494.
18. Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18:2145-2151.
19. Elford J, Ibrahim F, Bukutu C, et al. Uptake of antiretroviral treatment among people living with HIV in London: ethnicity, gender and sexual orientation. Sex Transm Infect. 2008;84:176-178.
20. Jain S, Schwarcz S, Katz M, et al. Elevated risk of death for African Americans with AIDS, San Francisco, 1996-2002. J Health Care Poor Underserved. 2006;17:493-503.